AND NONTUBERCULOUS MYCOBACTERIAL INFECTIONS “Tuberculosis appears to be as old as humanity itself.” Despite many advancements since the 1882 identification of as the causative agent of tuberculosis, it remains one of the top 10 causes of death worldwide and threatens the effectiveness of our therapeutic arsenal. In 2015, 1.8 million people died of tuberculosis and almost half a million new cases of multidrug-resistant tuberculosis were diagnosed. For Dr. Schlossberg assembled an international team of experts to write about nearly every facet of the prevention, diagnosis, and treatment of tuberculosis and nontuberculous mycobacterial infections. In addition to presenting the latest clinical data, epidemiological findings, and policy and strategy recommendations of the World Health Organization, four new chapters cover topics of critical importance: Other chapters provide detailed information on the clinical, public health, and policy aspects of tracking and treating tuberculosis, including: The seventh edition of is an essential resource for anyone working to prevent and treat tuberculosis and associated infections, from infectious disease specialists and pulmonologists to scientists, policymakers, and epidemiologists. Global TB Programme, World Health Organization “ Infectious Disease Division, Winthrop-University Hospital National Jewish Hospital (from a previous edition) (from a previous edition)If you are looking for online access to the latest clinical microbiology content, please visit www.wiley.com/learn/clinmicronow.